Smoking cessation is the process of stopping nicotine consumption through smoking. Specifically tobacco containing nicotine. Smoking tobacco can be addictive and can lead to dependencies to nicotine.
- The purpose of this study is to look at a drug called cytisinicline to see how effective it is at enabling people to quit smoking as compared to a placebo, which is an inactive substance. The study will last approximately 24 weeks with 19 visits to our office and one phone call. Dosing will be an oral medication, taken 3 times per day.
- Males or females 18 or older
- Smoking at least 10 cigarettes per day
- Failed to quit smoking at least once
- Motivated to quit
- Willing to quit 5-7 days after starting the study
- Willing to adhere to the time and compliance requirements
- Insurance is not required
If Qualified & you Participate you will Receive;
- Study-related care at no cost
- Highest standards of care overseen by a licensed Physician
- Compensation for time and travel
Fill out the form on the right-hand side of the page and see if you qualify for our clinical trial →